SeaStar Medical Holding Corporation (ICU) Stock

Healthcare · Biotechnology · Member of Other US Stocks

SeaStar Medical Holding Corporation (ICU) closed at USD 3.01 on 2026-10-14, a change of -47.4 % over the past year, with a market capitalization of USD 16.1M.

SeaStar Medical Holding Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

SeaStar Medical Holding Corporation key figures

Previous close

USD 3.01 (2026-10-14)

1-year change

-47.4 %

Market cap

USD 16.1M

Enterprise value

USD 6.66M

P/E ratio (trailing)

-1.03

P/E ratio (forward)

-1.19

EPS (trailing)

-2.97

EPS (forward)

-2.57

PEG ratio

n/a

Price to book

3.04

Revenue growth

82 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.20

Employees

18

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for SeaStar Medical Holding Corporation and compare it with other stocks.